Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Boehringer Ingelheim
Cerilliant
Mallinckrodt
Dow
Fuji
Covington
McKinsey

Generated: December 14, 2018

DrugPatentWatch Database Preview

Drug Price Trends for ALCLOMETASONE DIPRO

« Back to Dashboard

Drug Price Trends for ALCLOMETASONE DIPRO

Average Pharmacy Cost for ALCLOMETASONE DIPRO

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ALCLOMETASONE DIPRO 0.05% CRM 68462-0300-65 1.12783 GM 2018-11-21
ALCLOMETASONE DIPRO 0.05% CRM 00168-0263-60 1.12783 GM 2018-11-21
ALCLOMETASONE DIPRO 0.05% CRM 51672-1306-01 1.61164 GM 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cipla
Colorcon
US Army
Accenture
Mallinckrodt
Queensland Health
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.